Then he tried to draw a distinction puzzling to anyone who has ever performed an online transaction: He said the product ��these health exchanges that few could get access to ��was good; it was the process that was problematic. He seemed genuinely to have no idea that for most Americans steeped in digital behavior, the product is the process. (His distinction is like an airline saying planes are remarkable feats of engineering, so pay no attention to the fact that you might be delayed for hours on the tarmac.)
Top 5 Paper Companies To Invest In Right Now: Omega Healthcare Investors Inc.(OHI)
Omega Healthcare Investors, Inc. operates as a real estate investment trust (REIT) in the United States. The company invests in healthcare facilities, principally long-term healthcare facilities in the United States. It provides lease or mortgage financing to qualified operators of skilled nursing facilities (SNFs), as well as to assisted living facilities (ALFs), independent living facilities (ILFs), and rehabilitation and acute care facilities. As of March 31, 2011, the company?s portfolio of real estate investments consisted of 400 healthcare facilities, including 370 SNFs, 10 ALFs, 5 specialty facilities, fixed rate mortgages on 13 SNFs, and 2 SNFs that are held-for-sale located in 35 states. Omega Healthcare Investors, Inc. has been qualified as a REIT for federal income tax purposes. As a REIT, it would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its shareholders. The company was founded in 1992 and is bas ed in Hunt Valley, Maryland.
Advisors' Opinion:- [By Jayson Derrick]
Aviv REIT (NYSE: AVIV) has agreed to sell itself to Omega Healthcare Investors (NYSE: OHI) for $3 billion, or $34.97 per share. Omega Healthcare expects the deal to be accretive to its FFO and FAD in 2015. Shares of Aviv REIT hit new 52-week highs of $34.71 before closing the day at $33.73, up 12.06 percent. Shares of Omega Healthcare lost 1.78 percent, closinga t $38.16.
- [By Dividends4Life]
This week a few companies answered the call and rewarded their shareholders with higher cash dividends:
Consolidated Edison Inc. (ED) engages in regulated electric, gas, and steam delivery businesses. January 16th the company increased its quarterly dividend 2.4% to $0.63 per share. The dividend is payable March 15, 2014, to stockholders of record on February 12, 2014. The yield based on the new payout is 4.7%.
Cousins Properties Incorporated (CUZ), a real estate investment trust (REIT), owns, develops, and manages real estate portfolio, as well as performs certain real estate-related services. January 16th the company increased its quarterly dividend 66.7% to $0.075 per share. The dividend is payable February 24, 2014, to stockholders of record on February 10, 2014. The yield based on the new payout is 2.8%.
Wisconsin Energy Corporation (WEC) generates and distributes electric energy, as well as distributes natural gas. The company operates in two segments, Utility Energy and Non-Utility Energy. January 16th the company increased its quarterly dividend 2% to $0.3900 per share. The dividend is payable March 1, 2014, to stockholders of record on February 14, 2014. The yield based on the new payout is 3.8%.
BlackRock Inc. (BLK) is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors. January 16th the company increased its quarterly dividend 14.9% to $1.93 per share. The dividend is payable March 24, 2014, to stockholders of record on March 7, 2014. The yield based on the new payout is 2.4%.
ONEOK Inc. (OKE) operates as a diversified energy company in the United States. January 15th the company increased its quarterly dividend 5.3% to $0.40 per share. The dividend is payable February 18, 2014, to stockholders of record on February 10, 2014. The yield based on the new payout is 2.5%.
Omega Healthcare Investors Inc. (OHI) is a real es
10 Best Net Payout Yield Stocks To Buy For 2014: Euro/Swiss(RF)
Regions Financial Corporation operates as the holding company for Regions Bank that provides a range of commercial, retail, and mortgage banking services in the United States. It offers various deposit products, including savings and transaction accounts; demand deposit accounts; money market accounts; and time deposits, such as certificate of deposits and individual retirement accounts. The company?s loan portfolio comprises commercial loans, such as commercial and industrial, and owner occupied commercial real estate mortgage and construction loans; investor real estate loans, including commercial real estate mortgage and construction loans; and consumer loans, which consist of residential first mortgage, home equity, indirect, consumer credit card, and other consumer loans. Regions Financial Corporation, through other subsidiaries, also provides regional brokerage and investment banking products and services, such as securities brokerage, trust, asset management, finan cial planning, mutual funds, securities underwriting, sales and trading, and investment banking services for individual and institutional investors; and insurance brokerage services for various lines of personal and commercial insurance comprising property, casualty, life, health, and accident. In addition, the company offers credit-related insurance, including title, term life, credit life, environmental, crop, and mortgage insurance; debt cancellation products; and equipment financing products primary for commercial clients. As of December 31, 2011, it operated approximately 2,100 ATMs and 1,726 banking offices in Alabama, Arkansas, Florida, Georgia, Illinois, Indiana, Iowa, Kentucky, Louisiana, Mississippi, Missouri, North Carolina, South Carolina, Tennessee, Texas, and Virginia. The company was founded in 1970 and is headquartered in Birmingham, Alabama.
Advisors' Opinion:- [By David Hanson and Matt Koppenheffer]
In this segment of The Motley Fool's everything-financials show,�Where the Money Is, banking analysts Matt Koppenheffer and David Hanson discuss second-quarter earnings from Regions Financial (NYSE: RF ) and give their takes on some other regional banks.
- [By Monica Gerson]
Regions Financial (NYSE: RF) is expected to report its Q4 earnings at $0.20 per share on revenue of $1.31 billion.
Unilever plc (NYSE: UL) is estimated to report its Q4 results.
- [By Amanda Alix]
Bank hacktavists are at it again, and this time Regions Financial (NYSE: RF ) was the target. The large regional bank's website was down part of the day last Friday, and the bank confirmed that it had been the victim of a distributed denial of service (DDoS) attack. Online customers were unable to access their accounts, or if they could, found that their login information or debit card transactions were being denied.
- [By GuruFocus]
Just ask Bruce Berkowitz. Over his career he has always tried to keep at least 30% of his fund in cash. He aimed to use the cash to buy the stocks that he wanted to buy at lower prices. But he faced extreme redemptions in 2011 as he had his worst year with the fund. He had to sell financial stocks such as Citigroup (C), Regions Financial (RF), etc., exactly at the time he wanted to average down. One of his largest holdings, Bank of America (BAC), dropped to around $4 a share. He loved the company and his original purchase price was far higher. He wanted to buy more, but he had no more cash. Just to see, the stock climbed almost 150% since.
10 Best Net Payout Yield Stocks To Buy For 2014: Synergy Pharmaceuticals Inc (SGYP)
Synergy Pharmaceuticals, Inc., incorporated on February 11, 1992, is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (GI), disorders and diseases. The Company�� lead product candidate is plecanatide, a guanylyl cyclase C (GC-C), receptor agonist, to treat GI disorders, primarily chronic constipation (CC), and constipation-predominant-irritable bowel syndrome (IBS-C). It is also developing SP-333, the second generation GC-C receptor agonist for the treatment of gastrointestinal inflammatory diseases, such as ulcerative colitis (UC). The Company�� active pharmaceutical ingredients (APIs) and the final formulated drug products are manufactured for it by third party contractors.
As of December 31, 2011, the Company was developing plecanatide, a synthetic hexadecapeptide designed to mimic the actions of the GI hormone uroguanylin, for the treatment of CC and IBS-C. Plecanatide is an agonist of GC-C receptor. As of December 31, 2011, the Company was dosing patients in an 800-patient Phase II/III clinical trial of plecanatide to treat. It is also developing a second generation GC-C receptor analog, SP-333, which is in pre-clinical development for the treatment of gastrointestinal inflammatory diseases. SP-333 is a synthetic analog of uroguanylin, a natriuretic hormone.
The Company competes with Ironwood Pharmaceuticals, Inc., Forest Laboratories, Inc., Takeda Pharmaceuticals America, Inc., Sucampo Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Shire Plc.
Advisors' Opinion:- [By Sean Williams]
Finally, Synergy Pharmaceuticals (NASDAQ: SGYP ) may have had the wildest week of them all. Synergy's share price spiked 16% on Tuesday as an analyst at Cantor Fitzgerald raised her peak sales estimate for plecanatide, the company's midstage drug for chronic idiopathic constipation and irritable bowel syndrome with constipation, to $1.58 billion from $1.05 billion, as clinical data has been stronger than expected. However, the company didn't return the favor to shareholders by -- the very next day, mind you ��announcing a secondary offering of 16.375 million shares. The downside of clinical-stage companies is the always apparent risk of dilution. Shares have lost 25% since their Tuesday close.
- [By Monica Gerson]
Breaking news
Time Warner Cable (NYSE: TWC) reported a drop in its third-quarter profit. Time Warner Cable's quarterly profit fell to $532 million, or $1.84 per share, from $808 million, or $2.60 per share, in the year-ago period. To read the full news, click here. Synergy Pharmaceuticals (NASDAQ: SGYP) today announced the start of a phase 2 clinical trial to evaluate the safety and efficacy of SP-333, its second-generation GC-C agonist and once-daily oral treatment, in adult patients with opioid-induced constipation (OIC). To read the full news, click here. Cigna (NYSE: CI) reported a 19% rise in its third-quarter earnings and lifted its full-year earnings outlook. To read the full news, click here. Charm Communications (NASDAQ: CHRM) announced today that the special committee of the Company's board of directors, consisting of independent directors Mr. Zhan Wang, Mr. Andrew J. Rickards and Mr. Gang Chen, has retained China Renaissance Securities (Hong Kong) Limited as its financial advisor and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP as its legal advisor. To read the full news, click here.Posted-In: Bank of America US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets
10 Best Net Payout Yield Stocks To Buy For 2014: Santos Ltd (STOSF)
Santos Limited is an oil and gas producer, supplying Australian and Asian customers. The Company is primarily engaged in the exploration for, and development, production, transportation and marketing of, hydrocarbons. The Company develops major oil and gas liquids businesses in Australia, and operates in all mainland states and the Northern Territory. The Company has exploration-led Asian portfolio, with a focus on three core countries: Indonesia, Vietnam and Papua New Guinea. The Company operates in four business units of Eastern Australia; Western Australia and Northern Territory; Asia Pacific, and Gladstone LNG (GLNG). The Asia Pacific operating segment includes operations in Indonesia, Papua New Guinea, Vietnam, India and Bangladesh. Advisors' Opinion:- [By MARKETWATCH]
LOS ANGELES (MarketWatch) -- Australian stocks fell early Wednesday, tracking a weak lead from the U.S. but with a few blue-chip miners higher after gains for some commodities overnight. The S&P/ASX 200 (AU:XJO) retreated 0.4% to 5,237.80 after similar losses for the main Wall Street indexes, with the Australian benchmark trading around its lowest level since October. Among the major decliners, Qantas Airways Ltd. (AU:QAN) (QUBSF) lost 2.5%, Harvey Norman Holdings Ltd. (AU:HVN) (HNORY) gave up 1.3%, and Incitec Pivot Ltd. (AU:IPL) (ICPVY) fell 1.8%. Santos Ltd. (AU:STO) (STOSF) fell 2.6% on indication it will miss its lowered production guidance for 2013, according to the Australian Financial Review. On the upside, top miners BHP Billiton Ltd. (AU:BHP) (BHP) and Rio Tinto Ltd. (AU:RIO) (RIO) rose 0.3% and 0.7%, respectively, while Fortescue Metals Group Ltd. (AU:FMG) (FSUMF) traded 1% higher. Shares of global shopping-mall developer Westfield Group Australia (AU:WDC) (WEFIF) were on halt
10 Best Net Payout Yield Stocks To Buy For 2014: Jabil Circuit Inc.(JBL)
Jabil Circuit, Inc., together with its subsidiaries, provides electronic manufacturing services and solutions worldwide. The company offers electronics and mechanical design, production, product management, and after-market services to companies in the aerospace, automotive, computing, consumer, defense, industrial, instrumentation, medical, networking, peripherals, solar, storage, and telecommunications industries. Its services comprise integrated design and engineering; component selection, sourcing, and procurement; automated assembly; design and implementation of product testing; parallel global production; enclosure services; and systems assembly, direct-order fulfillment, and configure-to-order services. The company also provides set-top boxes, mobility products, and display products, as well as peripheral products, such as printers and point of sale terminals; and aftermarket services consisting of warranty and repair services. Jabil Circuit, Inc. was founded in 196 6 and is headquartered in St. Petersburg, Florida.
Advisors' Opinion:- [By Monica Gerson]
Jabil Circuit (NYSE: JBL) is projected to post a Q3 loss at $0.09 per share on revenue of $3.60 billion. Jabil Circuit shares rose 0.15% to $20.00 in after-hours trading.
- [By Maria Armental var popups = dojo.query(".socialByline .popC"); popups.forEach]
Jabil Circuit Inc.(JBL) swung to a loss in the fiscal third quarter as the contract electronics manufacturer reported a drop in revenue and significant restructuring costs, continuing a downward trend from the earlier quarter.
- [By DailyFinance Staff]
The looming Fed taper has been the talk of Wall Street for months, but it still came as a surprise to investors when it actually happened. Stocks rallied Wednesday following the Fed's decision to cut its $85 billion a month purchase of bonds by $10 billion, beginning in January. Outgoing Fed Chairman Ben Bernanke said the economy continues to "make progress." The Dow Jones industrial average (^DJI) soared 292 points on the news, its third biggest one-day gain this year. The Dow also hit a closing high, as did the Standard & Poor's 500 index (^GPSC), which gained 29 points. And the Nasdaq composite (^IXIC) rose 46 points. Consider it Bernanke's final present to the market before he retires from his position atop the Fed. Among the big blue chip winners, 3M (MMM) rose 3 percent, while Exxon Mobil (XOM), Chevron (CVX) and Goldman Sachs (GS) all rose 2 percent. But Microsoft (MSFT) was flat, reflecting across the board weakness in tech stocks. Many of the biggest players on the Nasdaq lost ground despite the overall market rally. Apple (AAPL) and Twitter (TWTR) ended lower and Tesla (TSLA) lost nearly 3 percent. Part of the reason for the tech weakness was an earnings miss and a weak forecast from Jabil Circuits (JBL), a key maker of electronics. Its shares plunged 20 percent. But homebuilders were strong following a report showing that housing starts last month rose to highest level in nearly six years. Lennar (LEN), which also posted strong earnings, jumped 6 percent. William Lyon Homes rose 4 percent, KB Homes (KBH) and Toll Brothers (TOL) each rose 3.5 percent. Ford (F) shares skidded more than 6 percent after lowering its profit forecast for next year. The company also warned that it may not meet its target for 2015 and 2016. In part, Ford blames the high expenses tied its planned launch of a record number of new vehicles next year. Finally, the movie theater chain AMC Entertainment (AMC) rose 5 percent from its $18 a share IPO price. This is exp
10 Best Net Payout Yield Stocks To Buy For 2014: Symmetry Medical Inc (SMA)
Symmetry Medical Inc. designs, develops, and produces implants and related surgical instruments and cases to orthopedic device manufacturers worldwide. It offers orthopedic implants that are used in reconstructive surgeries to replace or repair hips, knees, and other joints, such as shoulders, ankles, and elbows; trauma implant systems, which are used primarily to reattach or stabilize damaged bone or tissue while the body heals; and spinal implant systems, including plates and screws used by orthopedic surgeons and neurosurgeons in the treatment of degenerative diseases, deformities, and injuries in various regions of the spine. The company also provides surgical instruments, such as knee cutting blocks, osteotome revision systems, reamers, and retractors used in hip, knee, and shoulder reconstruction procedures, as well as in spinal, trauma, and other implant procedures. In addition, it produces a range of plastic, metal, and hybrid orthopedic cases to store, transport, and arrange surgical instruments and related implant systems, and other medical devices for orthopedic device manufacturers; endoscopy cases for endoscope sterilization; dental cases used in dental implant and general dental procedures; sterilization containers for the sterilization of various surgical instruments; and other cases for arthroscopy, osteobiologic, cardiovascular, ophthalmology, and diagnostic imaging, as well as ear, nose, and throat procedures. Further, the company engages in the design, engineering, and manufacturing of aerospace products comprising net shaped aerofoils and non-rotating aircraft engine forgings produced for the aerospace customers; and offers aerospace machining capabilities. The company was founded in 1976 and is headquartered in Warsaw, Indiana.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Symmetry Medical (NYSE: SMA ) , whose recent revenue and earnings are plotted below. - [By Sean Williams]
What: Shares of Symmetry Medical (NYSE: SMA ) , a medical device solutions and surgical instruments manufacturer, dipped as much as 17% after the company updated its second-quarter and full-year financial guidance.
- [By Roberto Pedone]
One under-$10 health care player that's starting to trend within range of triggering a near-term breakout trade is Symmetry Medical (SMA), which designs, develops and produces medical device solutions and surgical instruments. This stock has been hit by the sellers in 2013, with shares off by 22%.
If you take a look at the chart for Symmetry Medical, you'll notice that this stock has been finding some buying interest over the last two months, each time it's pulled back to around $7.75 a share. That action has started to form a bottoming pattern for SMA near that $7.75 level. Shares of SMA are now starting to challenge its 50-day moving average of $8.20 a share. That move is quickly pushing shares of SMA within range of triggering a near-term breakout trade.
Traders should now look for long-biased trades in SMA if it manages to break out above some near-term overhead resistance levels at $8.29 to $8.60 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 129,189 shares. If that breakout hits soon, then SMA will set up to re-test or possibly take out its next major overhead resistance levels at $9.40 to its 200-day moving average of $9.59 a share. Any high-volume move above those levels will then put $10.50 to $11 into range for shares of SMA.
Traders can look to buy SMA off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support at $7.75 a share, or at $7.44 a share. One can also buy SMA off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
10 Best Net Payout Yield Stocks To Buy For 2014: Lean Hogs (HE)
Hawaiian Electric Industries, Inc., through its subsidiaries, primarily engages in electric utility and banking businesses primarily in Hawaii. The company is involved in the production, purchase, transmission, distribution, and sale of electricity from renewable energy sources, such as wind, solar, photovoltaic, geothermal, wave, hydroelectric, sugarcane waste, municipal waste, and other biofuels, as well as from fuel oil. It distributes and sells electricity on the islands of Oahu, Hawaii, Maui, Lanai, and Molokai; and serves suburban communities, resorts, the United States armed forces installations, and agricultural operations. As of December 31, 2011, the company had net generating and firm purchased capability of 2,326.9 megawatts. It also engages in providing banking and other financial services, such as accepting savings accounts, checking accounts, money market accounts, and certificates of deposit; and providing loans comprising residential and commercial real es tate, residential mortgage, construction and development, multifamily residential and commercial real estate, consumer, and commercial loans to consumers and business. The company operated 57 branches and 119 automated teller machines. Hawaiian Electric Industries, Inc. was founded in 1891 and is based in Honolulu, Hawaii.
Advisors' Opinion:- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Utilities stocks gained Friday, with Korea Electric Power (NYSE: KEP) leading advancers. Meanwhile, gainers in the sector included Huaneng Power International (NYSE: HNP), with shares up 1.8 percent, and Hawaiian Electric Industries (NYSE: HE), with shares up 1.4 percent. - [By Geoff Gannon]
路 Within 5 or 6 hours��(he) found 20 stocks selling at 2 or 3 (times) earnings with strong balance sheets.
路 Korea rebuilt itself in a big way post 1998. Companies overbuilt their balance sheets.
- [By shash63]
Ever since the evolution of electricity, demand for electric power has been been rising exponentially. To satisfy America's need for the ever growing demand of power; various companies are looking to generate more power by use of conventional and non conventional methods. Hawaiian Electric Industries (HE) is one such company in the U.S. that supplies 95% of electricity in Hawaii with its customer base of over 450,000.
- [By Jake L'Ecuyer]
Utilities shares dropped by 0.31 percent in the US market today. Among the sector stocks, Hawaiian Electric Industries (NYSE: HE) was down more than 2.9 percent, while Edison International (NYSE: EIX) tumbled around 1.4 percent.
No comments:
Post a Comment